Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
DRIO DarioHealth Corp
- Stocks
- Healthcare
- NASDAQ: DRIO
Price (delayed)
$0.7102
Market cap
$31.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.56
Enterprise value
$33.7M
DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software
Highlights
DarioHealth's gross profit has soared by 180% YoY and by 11% from the previous quarter
The gross margin has soared by 90% YoY and by 7% QoQ
The company's net income rose by 17% YoY but it fell by 4.8% QoQ
DRIO's equity is down by 6% year-on-year but it is up by 2.3% since the previous quarter
The quick ratio has decreased by 34% YoY and by 18% QoQ
Key stats
What are the main financial stats of DRIO
Market
Valuations
Earnings
Shares outstanding
43.95M
Market cap
$31.21M
Enterprise value
$33.7M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
1.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.2
Revenue
$28.03M
Gross profit
$14.72M
Operating income
-$49.3M
Net income
-$44.8M
EBIT
-$44.64M
EBITDA
-$37.28M
Free cash flow
-$32.24M
Per share
Balance sheet
Liquidity
EPS
-$0.56
EPS diluted
-$0.56
Free cash flow per share
-$0.68
Book value per share
$1.77
Revenue per share
$0.59
TBVPS
$0.86
Total assets
$115.6M
Total liabilities
$41.9M
Debt
$30.34M
Equity
$73.7M
Working capital
$19.41M
Debt to equity
0.41
Current ratio
2.01
Quick ratio
1.77
Net debt/EBITDA
-0.07
Margins
Efficiency
Dividend
EBITDA margin
-133%
Gross margin
52.5%
Net margin
-159.8%
Operating margin
-175.9%
Return on assets
-39.3%
Return on equity
-67.3%
Return on invested capital
-157.6%
Return on capital employed
-46.3%
Return on sales
-159.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRIO stock price
How has the DarioHealth stock price performed over time
Intraday
2.78%
1 week
-1.36%
1 month
7.61%
1 year
-35.44%
YTD
-9.66%
QTD
16.01%
Financial performance
How have DarioHealth's revenue and profit performed over time
Revenue
$28.03M
Gross profit
$14.72M
Operating income
-$49.3M
Net income
-$44.8M
Gross margin
52.5%
Net margin
-159.8%
DarioHealth's gross profit has soared by 180% YoY and by 11% from the previous quarter
The gross margin has soared by 90% YoY and by 7% QoQ
The revenue rose by 47% year-on-year and by 3.7% since the previous quarter
DRIO's operating margin is up by 46% year-on-year and by 18% since the previous quarter
Price vs fundamentals
How does DRIO's price correlate with its fundamentals
Growth
What is DarioHealth's growth rate over time
Valuation
What is DarioHealth stock price valuation
P/E
N/A
P/B
0.4
P/S
1.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.2
DRIO's EPS has soared by 67% year-on-year and by 8% since the previous quarter
The P/B is 76% lower than the 5-year quarterly average of 1.6 and 22% lower than the last 4 quarters average of 0.5
DRIO's equity is down by 6% year-on-year but it is up by 2.3% since the previous quarter
DRIO's P/S is 85% below its 5-year quarterly average of 7.6 and 31% below its last 4 quarters average of 1.7
The revenue rose by 47% year-on-year and by 3.7% since the previous quarter
Efficiency
How efficient is DarioHealth business performance
DRIO's ROS is up by 46% year-on-year and by 3.5% since the previous quarter
DRIO's ROA is up by 25% YoY but it is down by 17% QoQ
DarioHealth's return on equity has increased by 21% YoY but it has decreased by 13% QoQ
The ROIC has contracted by 9% from the previous quarter but it has grown by 2.9% YoY
Dividends
What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRIO.
Financial health
How did DarioHealth financials performed over time
The total assets is 176% greater than the total liabilities
The quick ratio has decreased by 34% YoY and by 18% QoQ
DarioHealth's current ratio has decreased by 32% YoY and by 18% from the previous quarter
The debt is 59% less than the equity
DRIO's equity is down by 6% year-on-year but it is up by 2.3% since the previous quarter
The company's debt to equity rose by 5% YoY but it fell by 2.4% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.